[LXRX] QoQ Quarter Result on 30-Sep-2012 [#Q3]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
07-Nov-2012
Financial Year
2012
Quarter
30-Sep-2012 [#Q3]
Profit Trend
QoQ- -13.91%
YoY- -13.16%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Quarter Result
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Revenue 214 360 218 372 199 300 343 -27.00%
PBT -29,080 -25,974 -24,873 -29,539 -25,459 -29,387 -33,845 -9.62%
Tax -333 540 -55,799 -576 -643 485 -56,267 -96.73%
NP -29,080 -25,974 -24,873 -29,539 -25,931 -29,868 -33,845 -9.62%
Tax Rate - - - - - - - -
Total Cost 29,294 26,334 25,091 29,911 26,130 30,168 34,188 -9.79%
Ratio Analysis
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
NP Margin -13,588.79 -7,215.00 -11,409.63 -7,940.59 -13,030.65 -9,956.00 -9,867.35 23.80%
Per Share
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
EPS -0.40 -0.35 -0.34 -0.42 -0.38 -0.44 -0.49 -12.66%
EPS Diluted -0.40 -0.35 -0.34 -0.42 -0.38 -0.44 -0.49 -12.66%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.